Interleukin-12 and infectious diseases: a potential novel therapy.

about

Interleukin-12 and infectious diseases: a potential novel therapy.

Item

http://www.wikidata.org/entity/Q47619814

description

1997 nî lūn-bûn

@nan

1997年の論文

@ja

1997年学术文章

@wuu

1997年学术文章

@zh-cn

1997年学术文章

@zh-hans

1997年学术文章

@zh-my

1997年学术文章

@zh-sg

1997年學術文章

@yue

1997年學術文章

@zh

1997年學術文章

@zh-hant

name

Interleukin-12 and infectious diseases: a potential novel therapy.

@en

Interleukin-12 and infectious diseases: a potential novel therapy.

@nl

type

Item

label

Interleukin-12 and infectious diseases: a potential novel therapy.

@en

Interleukin-12 and infectious diseases: a potential novel therapy.

@nl

prefLabel

Interleukin-12 and infectious diseases: a potential novel therapy.

@en

Interleukin-12 and infectious diseases: a potential novel therapy.

@nl

P1476

Interleukin-12 and infectious diseases: a potential novel therapy.

@en

P2093

Carr JA

http://www.w3.org/2001/XMLSchema#string

Mulqueen MJ

http://www.w3.org/2001/XMLSchema#string

P2860

Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells

Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor

CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma

Homology of the p40 subunit of natural killer cell stimulatory factor (NKSF) with the extracellular domain of the interleukin-6 receptor

Switch from a type 2 to a type 1 T helper cell response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin 12 and Pentostam

Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity

Interleukin 2 induces CD8+ T cell-mediated suppression of human immunodeficiency virus replication in CD4+ T cells and this effect overrides its ability to stimulate virus expression.

Interleukin 12 suppresses autoantibody production by reversing helper T-cell phenotype in hepatitis B e antigen transgenic mice.

Protection of mice from Mycobacterium avium infection by recombinant interleukin-12

Interferon gamma-independent effects of interleukin 12 administered during acute or established infection due to Leishmania major.

P304

985-1000

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.6.8.985

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1997-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15989657

http://www.w3.org/2001/XMLSchema#string

P921

interleukin